Skip to main content
Log in

Effect of topical and intraventricular antibiotics used during ventriculoperitoneal shunt insertion on the rate of shunt infection—a meta-analysis

  • Review Article - Infection
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Introduction

The ventriculoperitoneal shunt is one of the most commonly performed neurosurgical procedures. One of the avoidable complications of shunt surgery is shunt infection. This PRISMA-compliant meta-analysis analysed the effectiveness of topical and/or intraventricular antibiotics in preventing shunt infections in patients undergoing shunt surgery.

Methods

Four databases were searched from inception to 30th June 2021. Only original articles comparing the rate of shunt infection with and without antibiotics were included. Random-effects meta-analysis was used to compare the effect of the use of antibiotics in preventing infection and subgroup analysis for finding differences in various antibiotics.

Results

The rate of shunt infection was 2.24% (53 out of 2362) in the topical antibiotic group in comparison to 5.24% (145 out of 2764) in the control group (p = 0.008). Subgroup analysis revealed that there is no significant difference between the antibiotics used.

Conclusions

Our meta-analysis found that the risk of shunt infection is significantly reduced with the use of topical and intraventricular antibiotics without any serious adverse effect. No side effects of topical or intraventricular antibiotics were reported in the included studies. Further prospective studies are required to establish the safety and optimal dosage of topical antibiotics for them to be used routinely in neurosurgical practice. They can be used in patients at high risk of developing shunt infections till such studies are available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kestle JRW, Holubkov R, Douglas Cochrane D et al (2016) A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr 17(4):391–396

    Article  Google Scholar 

  2. Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(1):1–48

    Google Scholar 

  3. Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99(5):831–839

    Article  Google Scholar 

  4. Raygor KP, Oh T, Hwang JY, Phelps RRL, Ghoussaini K, Wong P, Silvers R, Ostling LR, Sun PP (2020) Ventriculoperitoneal shunt infection rates using a standard surgical technique, including topical and intraventricular vancomycin: the Children’s Hospital Oakland experience. J Neurosurg Pediatr 26:504–512. https://doi.org/10.3171/2020.4.PEDS209

    Article  PubMed  Google Scholar 

  5. Krause M, Mahr CV, Schob S, Nestler U, Wachowiak R (2019) Topical instillation of vancomycin lowers the rate of CSF shunt infections in children. Childs Nerv Syst 35(7):1155–1157

    Article  CAS  Google Scholar 

  6. Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI (2010) Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 66(2):284–289; discussion 289

  7. Lakomkin N, Hadjipanayis CG (2021) The role of prophylactic intraventricular antibiotics in reducing the incidence of infection and revision surgery in pediatric patients undergoing shunt placement. Neurosurgery 88(2):301–305

    Article  Google Scholar 

  8. Isaacs AM, Riva-Cambrin J, Yavin D, Hockley A, Pringsheim TM, Jette N, Lethebe BC, Lowerison M, Dronyk J, Hamilton MG (2018) Age-specific global epidemiology of hydrocephalus: systematic review, metanalysis and global birth surveillance. PLoS ONE 13(10):e0204926

    Article  Google Scholar 

  9. Konstantelias AA, Vardakas KZ, Polyzos KA, Tansarli GS, Falagas ME (2015) Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis. J Neurosurg 122(5):1096–1112

    Article  Google Scholar 

  10. Yakut N, Soysal A, Kadayifci EK et al (2018) Ventriculoperitoneal shunt infections and re-infections in children: a multicentre retrospective study. Br J Neurosurg 32(2):196–200

    Article  Google Scholar 

  11. Rozzelle CJ, Leonardo J, Li V (2008) Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2(2):111–117

    Article  Google Scholar 

  12. Arts SH, Boogaarts HD, van Lindert EJ (2019) Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection. Cochrane Database Syst Rev 6:CD012902

  13. Ragel BT, Schmidt RH (2006) Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents. J Neurosurg 105:6

    Article  Google Scholar 

  14. Mallucci CL, Jenkinson MD, Conroy EJ et al (2019) Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation. Lancet Lond Engl 394(10208):1530–1539

    Article  CAS  Google Scholar 

  15. van Lindert EJ, van Bilsen M, van der Flier M, Kolwijck E, Delye H, ten Oever J (2018) Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: a retrospective cohort study. PLoS ONE 13(1):e0190249

    Article  Google Scholar 

  16. Ng K, Mabasa VH, Chow I, Ensom MHH (2014) Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults. Neurocrit Care 20(1):158–171

    Article  CAS  Google Scholar 

  17. Simon TD, Hall M, Riva-Cambrin J, Albert JE, Jeffries HE, Lafleur B, Dean JM, Kestle JRW, Hydrocephalus Clinical Research Network (2009) Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article J Neurosurg Pediatr 4(2):156–165

    Article  Google Scholar 

  18. Higgins JPT, Savovic J, Page M, Elbers R, Sterne J. Chapter 8: Assessing risk of bias in a randomized trial. In: Cochrane Handbook for Systematic Reviews of Interventions version 62 (updated February 2021) [Internet]. Cochrane, 2021; [cited 2021 Dec 8]. Available from: https://training.cochrane.org/handbook/current/chapter-08

  19. Theophilius CS, Siregar J (2011) A randomised control trial on the use of topical methicillin in reducing post- operative ventriculoperitoneal shunt infection. Malays J Med Sci 18(1):30–37

    Google Scholar 

  20. Harrer M, Cuijpers P, FT A, Ebert DD (2021) Doing meta-analysis with R: a hands-on guide, 1st edn. Chapman & Hall/CRC Press, Boca Raton, FL and London

    Book  Google Scholar 

  21. Bullock R, van Dellen JR, Ketelbey W, Reinach SG (1988) A double-blind placebo-controlled trial of perioperative prophylactic antibiotics for elective neurosurgery. J Neurosurg 69(5):687–691

    Article  CAS  Google Scholar 

  22. Casey ATH, Kimmings EJ, Kleinlugtebeld AD, Taylor WaS, Harkness WF, Hayward RD (1997) The long-term outlook for hydrocephalus in childhood. Pediatr Neurosurg 27(2):63–70

    Article  CAS  Google Scholar 

  23. Goda R, Ganesh kumar A, Katiyar V, Sharma R, Gurjar HK, Chaturvedi A, Sahu R, Rai HIS, Vora Z (2021) Efficacy of antimicrobial medicated ventricular catheters: a network meta-analysis with trial sequential analysis. Neurosurg Rev. https://doi.org/10.1007/s10143-021-01532-2

    Article  PubMed  Google Scholar 

  24. Beckman JM, Amankwah EK, Tetreault LL, Tuite GF (2015) Reduction in CSF shunt infection over a 10-year period associated with the application of concentrated topical antibiotic powder directly to surgical wounds prior to closure. J Neurosurg Pediatr 16(6):648–661

    Article  Google Scholar 

  25. Moussa WMM, Mohamed MAA (2016) Efficacy of postoperative antibiotic injection in and around ventriculoperitoneal shunt in reduction of shunt infection: a randomized controlled trial. Clin Neurol Neurosurg 143:144–149

    Article  Google Scholar 

  26. Kalangu KKN, Esene IN, Dzowa M, Musara A, Ntalaja J, Badra AK (2020) Towards zero infection for ventriculoperitoneal shunt insertion in resource-limited settings: a multicenter prospective cohort study. Childs Nerv Syst 36(2):401–409

    Article  Google Scholar 

  27. Piatt JH, Garton HJL (2008) Clinical diagnosis of ventriculoperitoneal shunt failure among children with hydrocephalus. Pediatr Emerg Care 24(4):201–210

    Article  Google Scholar 

  28. Drake JM, Kestle JR, Milner R et al (1998) Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43(2):294–303; discussion 303–305

  29. Stoodley P, Braxton EE, Nistico L, Hall-Stoodley L, Johnson S, Quigley M, Post JC, Ehrlich GD, Kathju S (2010) Direct demonstration of staphylococcus biofilm in an external ventricular drain in a patient with a history of recurrent ventriculoperitoneal shunt failure. Pediatr Neurosurg 46(2):127–132

    Article  Google Scholar 

  30. Zhang Q, Chen H, Zhu C, Chen F, Sun S, Liang N, Zheng W (2019) Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury. Exp Ther Med 17(6):4605–4609

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Dr Ganesh VL—data collection, writing manuscript, approved final draft. Dr Kanwaljeet Garg—conceptualization, data collection, analysis, writing manuscript, approved final draft. Dr Vivek Tandon—approved final draft, supervision. Dr Sachin A Borkar—approved final draft, supervision. Prof GD Satyarthi—approved final draft, supervision. Prof Manmohan Singh—approved final draft, supervision. Prof P S Chandra—approved final draft, supervision. Prof S S Kale—approved final draft, supervision.

Corresponding author

Correspondence to Kanwaljeet Garg.

Ethics declarations

Ethics approval

Not required as patient data was not used.

Consent to participate

Patient consent was taken.

Consent for publication

Patient consent for publication was taken.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

No portion of the contents of this paper has not been presented or published previously.

This article is part of the Topical Collection on Infection

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

VL, G., Garg, K., Tandon, V. et al. Effect of topical and intraventricular antibiotics used during ventriculoperitoneal shunt insertion on the rate of shunt infection—a meta-analysis. Acta Neurochir 164, 1793–1803 (2022). https://doi.org/10.1007/s00701-022-05248-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-022-05248-0

Keywords

Navigation